Literature DB >> 5863560

[Heparin tolerance in hyperlipemics].

F Holzknecht, F Spöttl.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1965        PMID: 5863560     DOI: 10.1007/bf01712062

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN: 0023-2173


× No keyword cloud information.
  14 in total

1.  [STUDIES ON THE POST HEPARINIC LIPOPRPTEIN LIPASE ACTIVITY IN 6 CASES OF ESSENTIAL HYPERLIPEMIA].

Authors:  F SANDHOFER; S SAILER; M HERBST; H BRAUNSTEINER
Journal:  Dtsch Med Wochenschr       Date:  1965-04-23       Impact factor: 0.628

2.  [ENDOGENOUS LIPOPROTEIN LIPASE ACTIVITY IN HUMAN PLASMA].

Authors:  F SANDHOFER; S SAILER; H BRAUNSTEINER
Journal:  Dtsch Med Wochenschr       Date:  1964-02-28       Impact factor: 0.628

3.  [A new method for the isolation of heparin from plasma based on a quantitative determination].

Authors:  N ZOELLNER; C BURGER; R BRAUN
Journal:  Hoppe Seylers Z Physiol Chem       Date:  1962-09-06

4.  Experimental studies of heparin-protamine activity with special reference to protamine inhibition of clotting.

Authors:  M N ANDERSEN; M MENDELOW; G A ALFANO
Journal:  Surgery       Date:  1959-12       Impact factor: 3.982

5.  [New determination method and clinical significance of antithrombin].

Authors:  J JURGENS
Journal:  Klin Wochenschr       Date:  1957-03-15

6.  [Protamin tolerance test as a modification of the heparin tolerance test and of protamin titration].

Authors:  F K BELLER; D STEICHELE
Journal:  Z Gesamte Exp Med       Date:  1957

7.  [Mechanism of protamine reversibility of the clearing action of heparin].

Authors:  S GERO; L PERENYI; M JAKAB; J GACS
Journal:  Klin Wochenschr       Date:  1957-09-15

8.  The determination of heparin in blood.

Authors:  L B JAQUES
Journal:  Acta Haematol       Date:  1949-07       Impact factor: 2.195

9.  ABOLISHMENT OF ALIMENTARY LIPEMIA FOLLOWING INJECTION OF HEPARIN.

Authors:  P F Hahn
Journal:  Science       Date:  1943-07-02       Impact factor: 47.728

10.  The nature of the anticoagulant effect of heparin, protamine, polybrene and toluidine blue.

Authors:  P OLLENDORFF
Journal:  Scand J Clin Lab Invest       Date:  1962       Impact factor: 1.713

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.